Literature DB >> 7539453

c-KIT expression enhances the leukemogenic potential of 32D cells.

Q Hu1, M Trevisan, Y Xu, W Dong, S A Berger, S D Lyman, M D Minden.   

Abstract

The growth of human leukemic cells in culture and in vivo is dependent upon the presence of hematopoietic growth factors. Most populations of human leukemic acute myeloblastic leukemia (AML) cells express c-Kit on their surface and respond to Kit ligand (KL) in culture. To determine if this interaction was of potential significance in vivo we used a mouse model system. 32D cells, a murine IL-3-dependent myeloid cell line, were rendered KL responsive by transfection of the murine c-Kit. After injection of 32D or 32D-Kit cells into syngeneic hosts, animals bearing 32D-Kit cells, but not 32D cells, became moribund and were killed. These animals had circulating leukemic blast cells, infiltration of bone marrow, spleen, brain, liver, lung, and kidney. Cells recovered from some of the animals continued to be dependent upon IL-3 or KL for growth while in other cases the cells were factor independent. This model illustrates that the constitutive expression of c-Kit enhances the leukemic potential of 32D cells. The model will be useful for studying the progression of leukemia in vivo and testing whether interruption of the interaction of Kit and KL can affect the growth of leukemic cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7539453      PMCID: PMC295935          DOI: 10.1172/JCI117954

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  58 in total

Review 1.  Clonogenic cells in acute myeloblastic leukemia.

Authors:  J D Griffin; B Löwenberg
Journal:  Blood       Date:  1986-12       Impact factor: 22.113

2.  Interleukin-6 enhances growth factor-dependent proliferation of the blast cells of acute myeloblastic leukemia.

Authors:  T Hoang; A Haman; O Goncalves; G G Wong; S C Clark
Journal:  Blood       Date:  1988-08       Impact factor: 22.113

3.  The effects of three recombinant growth factors, IL-3, GM-CSF, and G-CSF, on the blast cells of acute myeloblastic leukemia maintained in short-term suspension culture.

Authors:  J Miyauchi; C A Kelleher; Y C Yang; G G Wong; S C Clark; M D Minden; S Minkin; E A McCulloch
Journal:  Blood       Date:  1987-09       Impact factor: 22.113

4.  Secretion of interleukin-1 by acute myeloblastic leukemia cells in vitro induces endothelial cells to secrete colony stimulating factors.

Authors:  J D Griffin; A Rambaldi; E Vellenga; D C Young; D Ostapovicz; S A Cannistra
Journal:  Blood       Date:  1987-10       Impact factor: 22.113

5.  Interleukin-1 induces human bone marrow-derived fibroblasts to produce multilineage hematopoietic growth factors.

Authors:  M Lee; G M Segal; G C Bagby
Journal:  Exp Hematol       Date:  1987-10       Impact factor: 3.084

6.  Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors.

Authors:  H Karasuyama; F Melchers
Journal:  Eur J Immunol       Date:  1988-01       Impact factor: 5.532

7.  Synergism between recombinant growth factors, GM-CSF and G-CSF, acting on the blast cells of acute myeloblastic leukemia.

Authors:  C Kelleher; J Miyauchi; G Wong; S Clark; M D Minden; E A McCulloch
Journal:  Blood       Date:  1987-05       Impact factor: 22.113

8.  Human recombinant multilineage colony stimulating factor (interleukin-3): stimulator of acute myelocytic leukemia progenitor cells in vitro.

Authors:  R Delwel; L Dorssers; I Touw; G Wagemaker; B Löwenberg
Journal:  Blood       Date:  1987-07       Impact factor: 22.113

9.  Expression of functional c-kit receptors rescues the genetic defect of W mutant mast cells.

Authors:  W S Alexander; S D Lyman; E F Wagner
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

10.  Autocrine stimulation of interleukin 1 beta in acute myelogenous leukemia cells.

Authors:  K Sakai; T Hattori; M Matsuoka; N Asou; S Yamamoto; K Sagawa; K Takatsuki
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

View more
  2 in total

Review 1.  Signaling pathways influencing SLF and c-kit-mediated survival and proliferation.

Authors:  Stuart A Berger
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

2.  Kit signaling through PI 3-kinase and Src kinase pathways: an essential role for Rac1 and JNK activation in mast cell proliferation.

Authors:  I Timokhina; H Kissel; G Stella; P Besmer
Journal:  EMBO J       Date:  1998-11-02       Impact factor: 11.598

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.